Urologix Inc

Urologix, Inc. is a privately held company based in Minneapolis, Minnesota. The company employs 51 people and generates an annual revenue of $50 million. Urologix develops, manufactures, markets, and distributes minimally invasive medical products designed to treat obstruction and symptoms associated with Benign Prostatic Hyperplasia (BPH). Their Cooled ThermoTherapy™ technology utilizes targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. Urologix also distributes the Prostiva® RF Therapy System, which delivers radio frequency energy directly to the prostate, reducing tissue constriction and relieving BPH symptoms. Both the Cooled ThermoTherapy™ and Prostiva® RF Therapy System offer safe, effective, and lasting relief from BPH symptoms and obstruction. The Prostiva® trademark is owned by Medtronic, Inc. and is used under license. For more information about Urologix and its products, visit their website at urologix.com.